Tacrolimus 0,5 Mg; 1 Mg; 5 Mg Austell 0,5 mg; 1 mg; 5 mg Hard gelatin capsules
PDF Leaflet Revision Date: 09 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Primary immunosuppression in organ transplant recipients.
Dosage (summary)
Initial oral dose: 0.10-0.20 mg/kg/day for liver; 0.15-0.40 mg/kg/day for kidney, in two divided doses.
Special Populations
- Liver impairment
- Kidney impairment
- Elderly patients
- Paediatric patients
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- CYP3A4 inducers
- Ciclosporin
- Grapefruit juice
Contraindications
- Hypersensitivity to tacrolimus
- Pregnancy
- Lactation
- Live vaccines
Common side effects
- Infections
- Neoplasms
- Anemia
- Hyperglycemia
- Tremor
Counselling Points
- Take on an empty stomach
- Monitor for signs of infection
- Avoid grapefruit juice
Serious warnings
- Medication errors may lead to graft rejection
- Increased risk of infections
- QT prolongation
Important Disclaimer
The Tacrolimus 0,5 Mg; 1 Mg; 5 Mg Austell 0,5 mg; 1 mg; 5 mg Hard gelatin capsules professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
